FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2584508002> ?p ?o ?g. }

• W2584508002 abstract "Background: Eosinophilic gastrointestinal disorders (EGID) are a group of inflammatory gastrointestinal disorders, characterised by inappropriate eosinophil infiltration and symptoms that affect one or more parts of the GI tract, in the absence of extra-intestinal causes. They include eosinophilic oesophagitis (EO), eosinophilic gastroenteritis (EG) and eosinophilic colitis (EC), all of which can occur following immunosuppression for liver transplantation. Aim: To present a review of the recent literature on EGID following immunosuppression for liver transplantation in order to clarify their diagnosis and treatment. Methods: We performed a PubMed search for EGID, eosinophilic oesophagitis (EO), eosinophilic gastroenteritis (EG) and eosinophilic colitis (EC), associated with liver transplantation, their clinical presentation, diagnosis and treatments. Results: In the liver transplant population, prevalence of EGID is up to one hundred times greater than the non-transplant population, making it a significant contributor to post-transplant morbidity. EGID affects individuals of all ages, favouring those in the third and fourth decades, and males over females. There is a strong association between these conditions and calcineurin inhibitors, tacrolimus and CsA, with tacrolimus appearing to confer a higher risk for the development of eosinophilic disorders. Diagnosis of EGID depends on endoscopic and histological features, due to similar non-specific symptomatology of EGID but distinct endoscopic and histological features. The mainstay of treatment for EO, EG and EC is systemic steroid therapy, however some specific therapies have been suggested including biologics such as mepolizumab (anti-IL-5 monoclonal antibody) for EO, octreotide (somatostatin analogue) for EG and montelukast (LTD4 receptor antagonist) for all three conditions. Empirical dietary elimination may also provide symptomatic relief. Conclusion: EGID is an important but under-recognised complication of immune suppression, particularly of the drugs that predominate current anti-rejection therapy for liver transplantation. They are quite common and likely to impact on the patient’s quality of life. In patients presenting with non-specific GI symptoms, there must be a high index of suspicion for EGID, prompting further investigation through upper and lower endoscopy and histological analysis. Modification of the immunosuppressive regime can contribute to reducing risk of relapse and treating active or refractory episodes. Therefore, in patients suffering from EGID, management of the their immune suppression becomes important in control of the condition, rendering EGID a key factor in the design of their tailored immunosuppression." @default.
• W2584508002 created "2017-02-10" @default.
• W2584508002 creator A5028521503 @default.
• W2584508002 date "2015-01-01" @default.
• W2584508002 modified "2023-09-24" @default.
• W2584508002 title "Eosinophilic GI Disorders (EGID) following Immunosuppression for Liver Transplantation" @default.
• W2584508002 cites W1536075536 @default.
• W2584508002 cites W1971860511 @default.
• W2584508002 cites W1980046230 @default.
• W2584508002 cites W1981862686 @default.
• W2584508002 cites W1984892132 @default.
• W2584508002 cites W1988327136 @default.
• W2584508002 cites W1991686402 @default.
• W2584508002 cites W1994197205 @default.
• W2584508002 cites W1997864710 @default.
• W2584508002 cites W1998112558 @default.
• W2584508002 cites W2004439696 @default.
• W2584508002 cites W2005795026 @default.
• W2584508002 cites W2013531570 @default.
• W2584508002 cites W2021881000 @default.
• W2584508002 cites W2022658537 @default.
• W2584508002 cites W2023079732 @default.
• W2584508002 cites W2027366519 @default.
• W2584508002 cites W2028190708 @default.
• W2584508002 cites W2033559734 @default.
• W2584508002 cites W2034453465 @default.
• W2584508002 cites W2040605890 @default.
• W2584508002 cites W2041718345 @default.
• W2584508002 cites W2046402341 @default.
• W2584508002 cites W2049053823 @default.
• W2584508002 cites W2056637653 @default.
• W2584508002 cites W2060173029 @default.
• W2584508002 cites W2060771250 @default.
• W2584508002 cites W2064764653 @default.
• W2584508002 cites W2066622846 @default.
• W2584508002 cites W2075010011 @default.
• W2584508002 cites W2078538526 @default.
• W2584508002 cites W2085854242 @default.
• W2584508002 cites W2088520106 @default.
• W2584508002 cites W2093983170 @default.
• W2584508002 cites W2094684363 @default.
• W2584508002 cites W2110421456 @default.
• W2584508002 cites W2134207741 @default.
• W2584508002 cites W2137513278 @default.
• W2584508002 cites W2154565827 @default.
• W2584508002 cites W2158183694 @default.
• W2584508002 cites W2159199639 @default.
• W2584508002 cites W2163655249 @default.
• W2584508002 cites W2168117972 @default.
• W2584508002 cites W2169817476 @default.
• W2584508002 cites W2171516474 @default.
• W2584508002 cites W2323763104 @default.
• W2584508002 cites W326789664 @default.
• W2584508002 doi "https://doi.org/10.4172/2167-0889.1000175" @default.
• W2584508002 hasPublicationYear "2015" @default.
• W2584508002 type Work @default.
• W2584508002 sameAs 2584508002 @default.
• W2584508002 citedByCount "4" @default.
• W2584508002 countsByYear W25845080022015 @default.
• W2584508002 crossrefType "journal-article" @default.
• W2584508002 hasAuthorship W2584508002A5028521503 @default.
• W2584508002 hasBestOaLocation W25845080021 @default.
• W2584508002 hasConcept C126322002 @default.
• W2584508002 hasConcept C142724271 @default.
• W2584508002 hasConcept C16005928 @default.
• W2584508002 hasConcept C2778643899 @default.
• W2584508002 hasConcept C2779134260 @default.
• W2584508002 hasConcept C2779609443 @default.
• W2584508002 hasConcept C2779758542 @default.
• W2584508002 hasConcept C2780252810 @default.
• W2584508002 hasConcept C2781065132 @default.
• W2584508002 hasConcept C2908647359 @default.
• W2584508002 hasConcept C2909675724 @default.
• W2584508002 hasConcept C2911091166 @default.
• W2584508002 hasConcept C71924100 @default.
• W2584508002 hasConcept C90924648 @default.
• W2584508002 hasConcept C99454951 @default.
• W2584508002 hasConceptScore W2584508002C126322002 @default.
• W2584508002 hasConceptScore W2584508002C142724271 @default.
• W2584508002 hasConceptScore W2584508002C16005928 @default.
• W2584508002 hasConceptScore W2584508002C2778643899 @default.
• W2584508002 hasConceptScore W2584508002C2779134260 @default.
• W2584508002 hasConceptScore W2584508002C2779609443 @default.
• W2584508002 hasConceptScore W2584508002C2779758542 @default.
• W2584508002 hasConceptScore W2584508002C2780252810 @default.
• W2584508002 hasConceptScore W2584508002C2781065132 @default.
• W2584508002 hasConceptScore W2584508002C2908647359 @default.
• W2584508002 hasConceptScore W2584508002C2909675724 @default.
• W2584508002 hasConceptScore W2584508002C2911091166 @default.
• W2584508002 hasConceptScore W2584508002C71924100 @default.
• W2584508002 hasConceptScore W2584508002C90924648 @default.
• W2584508002 hasConceptScore W2584508002C99454951 @default.
• W2584508002 hasIssue "02" @default.
• W2584508002 hasLocation W25845080021 @default.
• W2584508002 hasOpenAccess W2584508002 @default.
• W2584508002 hasPrimaryLocation W25845080021 @default.
• W2584508002 hasRelatedWork W1484691226 @default.
• W2584508002 hasRelatedWork W1971808798 @default.
• W2584508002 hasRelatedWork W2017481360 @default.
• W2584508002 hasRelatedWork W2037578617 @default.

• next